| HOME >> BIOLOGY >> TECHNOLOGY |
This news release, and the conference call referenced here, may contain
statements concerning certain trends, expectations, forecasts, estimates,
or other forward-looking information affecting or relating to the Company
or its industry that are intended to qualify for the protections afforded
"forward-looking statements" under the Private Securities Litigation Reform
Act of 1995 and other laws and regulations. Forward-looking statements
speak only as to the date of this report, and may be identified by the use
of forward-looking terms such as "may," "will," "expects," "believes,"
"anticipates," "plans," "estimates," "projects," "targets," "forecasts,"
"potential," "confidence," and "seeks," or the negative of such terms or
other variations on such terms or comparable terminology. Many important
factors could cause actual results to differ materially from those in the
forward-looking statements including, without limitation, disruption of
production or supplies, changes in market conditions, political events,
pending or future claims or litigation, competitive factors, technology
advances, actions of regulatory agencies, and changes in government
regulations or the application or interpretation thereof. Other risk
factors are described in the Company's Form 10-K and other securities
filings. Many of these important factors are outside STERIS's control. No
assurances can be provided as to any outcome from litigation, regulatory
action, administrative proceedings, government investigations, warning
letters, cost reductions, business strategies, level of share repurchases,
earnings and revenue trends, expense reduction or other future financial
results. Unless legally required, the Company does not undertake to update
or revise any forward-looking statements even if events make clear that any
projected results, express or implied, will not be realized. Other
poten
'/>"/>
| SOURCE STERIS Corporation Copyright©2008 PR Newswire. All rights reserved |